Dr. Jeffrey Leyton, Associate Professor at Université de Sherbrooke, will present his research on nuclear-targeting pharmaceuticals in this online research seminar.
Increasing our understanding of the fundamental principles of transport into the cell nucleus for creating effective next-generation nuclear-targeting pharmaceuticals.
Do not miss this research seminar by Dr. Jeffrey Leyton on August 16th! The seminar will be in English with a bilingual Q&A session. RSVP on Evenbright.